Results 31 to 40 of about 7,334 (206)

Prolonged hypotension induced by ingesting a topical minoxidil solution: analysis of minoxidil and its metabolites

Acute Medicine & Surgery, 2016
Case A 47‐year‐old man ingested 60 mL of a topical solution (3,000 mg minoxidil) and presented with prolonged hypotension. Treatment with dopamine hydrochloride and noradrenaline provided blood pressure control.
Satoshi Kikuchi, Yuji Fujita, Makoto Onodera, Yasuhisa Fujino, Yoshihiro Inoue   +4 more
doaj   +1 more source

Effect of High-Dose Topical Minoxidil on Erythrocyte Quality in SKH1 Hairless Mice

Animals, 2020
SKH1 hairless mice are widely used in carcinogenesis and dermatology research due to their bare skin, as exposure to different agents is facilitated. Minoxidil is a cosmetic drug that is recognized as a mitogenic agent, and mitogens are suggested to have
Eduardo Naranjo-Vázquez, María Guadalupe Sánchez-Parada, Belinda Claudia Gómez-Meda, Ana Lourdes Zamora-Perez, Martha Patricia Gallegos-Arreola, Ana Elizabeth González-Santiago, Guillermo Moisés Zúñiga-González   +6 more
doaj   +1 more source

New Target for Minoxidil in the Treatment of Androgenetic Alopecia

Drug Design, Development and Therapy, 2023
Yuqing Shen,1 Yuqi Zhu,1 Li Zhang,1 Jiayi Sun,1 Bo Xie,2 Hongyan Zhang,2 Xiuzu Song2 1Department of Dermatology, Hangzhou Third People’s Hospital, Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2Department of Dermatology ...
Shen Y, Zhu Y, Zhang L, Sun J, Xie B, Zhang H, Song X   +6 more
doaj  

Infantile generalized hypertrichosis caused by topical minoxidil [PDF]

Anais Brasileiros de Dermatologia, 2016
Rare cases of hypertrichosis have been associated with topically applied minoxidil. We present the first reported case in the Brazilian literature of generalized hypertrichosis affecting a 5-year-old child, following use of minoxidil 5%, 20 drops a day ...
Greice Rampon, Caroline Henkin, Paulo Ricardo Martins de Souza, Hiram Larangeira de Almeida Jr   +3 more
doaj   +1 more source

Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride

Indian Dermatology Online Journal, 2015
Background: Finasteride acts by reducing dihydrotestosterone levels, thereby inhibiting miniaturization of hair follicles in patients with androgenetic alopecia (AGA).
B S Chandrashekar, T Nandhini, Vani Vasanth, Rashmi Sriram, Shreya Navale   +4 more
doaj   +1 more source

Minoxidil: a comprehensive review

Journal of Dermatological Treatment, 2021
Topical minoxidil (5% foam, 5% solution, and 2% solution) is FDA-approved for androgenetic alopecia (AGA) in men and women.Mechanism of action: Minoxidil acts through multiple pathways (vasodilator, anti-inflammatory agent, inducer of the Wnt/β-catenin signaling pathway, an antiandrogen), and may also affect the length of the anagen and telogen phases ...
A. K. Gupta, M. Talukder, M. Venkataraman, M. A. Bamimore   +3 more
openaire   +3 more sources

The efficacy of topical minoxidil 2% versus topical botanically derived inhibitors of 5 alpha reductase in treatment of female pattern hair loss by trichoscopy

Journal of the Egyptian Women’s Dermatologic Society, 2019
Background Female pattern hair loss (FPHL) is a distressing common problem. Minoxidil is the only FDA approved medical treatment for FPHL. However, the off-label botanically derived 5-alpha reductase inhibitors (5αRIs) are commonly used despite ...
Fairouz K Badran, Rania E Abd El Maksoud, Mona M Ibrahim Moawad   +2 more
doaj   +1 more source

Simultaneous determination of minoxidil and minoxidil sulfate by high-performance liquid chromatography with UV-detection and its applications

Medicine in Drug Discovery, 2020
Aims: Minoxidil is a hair growth drug for treating androgenetic alopecia. Although minoxidil is generally administered as a topical formulation, this prodrug must be converted to its active form (minoxidil sulfate) by sulfotransferase in hair follicle ...
Mio Ichida, Chiharu Fujita, Rena Sumie, Ryotaro Miyano, Hajime Inoue   +4 more
doaj  

Minoxidil in trichological practice

Медицинский совет, 2018
Management of patients with alopecia is still a challenging task. Minoxidil is a pyrimidine derivative, a potent KATP channel opener, and has been shown to act as a vasodilating agent.
O. Yu. Olisova, I. P. Gostroverkhova
doaj   +1 more source

Efficacy of autologous platelet-rich plasma therapy versus topical Minoxidil in men with moderate androgenetic alopecia: a randomized open-label trial

Journal of Dermatological Treatment, 2023
Background Platelet-rich plasma (PRP) is an adjunctive treatment in androgenetic alopecia (AGA). Its role as a monotherapy, when compared to FDA-approved therapies in moderate grades of androgenetic alopecia is not established.
Mithinkumar Balasundaram, Rashmi Kumari, Sivaranjini Ramassamy   +2 more
doaj   +1 more source